TP53 Mutation Is Associated With a Poor Clinical Outcome for Non-Small Cell Lung Cancer: Evidence From a Meta-Analysis

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2016.1057
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

P3.03-28 LKB1 Mutation Status Is Associated With Poor Radiation Outcome in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

LINK‑A lncRNA Is Upregulated in Metastatic Non‑small Cell Lung Cancer and Is Associated With Poor Prognosis

Oncology Letters
Cancer ResearchOncology
2019English

Sleeve Lobectomy Versus Pneumonectomy for Non-Small Cell Lung Cancer: A Meta-Analysis

World Journal of Surgical Oncology
SurgeryOncology
2012English

Upregulated Expression of miR-421 Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer

Cancer Management and Research
Oncology
2018English

P3.03-21 CXCR4 Overexpression Is Associated With Poor Survival Outcome After Recurrence in Early Stage Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

ERCC1 mRNA Expression Is Associated With the Clinical Outcome of Non-Small Cell Lung Cancer Treated With Platinum-Based Chemotherapy

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2014English

Adiponectin Is Associated With Poor Prognosis in Carcinoma Patients: Evidence From a Meta-Analysis

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2015English

Outcome Analysis of Phase I Trial Patients With Metastatic KRAS and/or TP53 Mutant Non-Small Cell Lung Cancer

Oncotarget
Oncology
2018English

MARCH8 Is Associated With Poor Prognosis in Non-Small Cell Lung Cancers Patients

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy